Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
While January has seen a number of improving analyst calls on real estate investment trusts (REITs), there have also been some downgrades. Take a look at three REITs that have recently received multiple analyst downgrades but still managed to show positive results this month:
Kimco Realty® (NYSE:KIM) (the "Company") today announced that it intends to complete a holding company reorganization (the "Reorganization"), which would restructure the Company as an Umbrella